|
In vitro activity of Isavuconazole against 1488 Aspergillus isolates - a pooled analysis of nine studies (click for details) |
|
|
|
Pulmonary aspergillosis in a burn patient (click for details) |
|
|
|
In vivo efficacy of voriconazole therapy in an invertebrate
model of Aspergillus fumigatus infection (click for details) |
|
|
|
Comparison of MycAssayTM Aspergillus real-time PCR
kit and ‘‘in-house’’ real-time PCR assay on culture
confirmed respiratory samples (click for details) |
|
|
|
Investigation for azole resistance mediating Aspergillus
fumigatus cyp51A gene mutations using improved PCR
assays and consecutive DNA sequence analysis in clinical
samples of immunocompromised patients (click for details) |
|
|
|
Evaluation of invasive fusariosis in haematological
patients: a 10-year retrospective study (click for details) |
|
|
|
Activity of posaconazole in invasive fungal infections
associated with a variety of moulds and yeasts (click for details) |
|
|
|
Aetiologies of prolonged cough in Thai adults: the roles of
Bordetella pertussis and atypical pathogens (click for details) |
|
|
|
Emergence in vivo of Aspergillus terreus with reduced
azole susceptibility and a CYP51A M220I alteration in a
cystic fibrosis patient (click for details) |
|
|
|
Central nervous system aspergillosis in Saint Petersburg,
Russia (click for details) |
|
|
